The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
1511 LIPIGET 20 ATORVASTATIN (AS ATORVASTATIN CALCIUM TRIHYDRATE) 20 MG FILM COATED TABLET ALU-ALU BLISTER HYPERCHOLESTEROLEMIA AND PREVENTION OF CARDIOVASCULAR DISSEASE NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 08 I 2956/07 10-FEB-2025 09-FEB-2030 View
1512 MANMOX 125 DRY SYRUP( GRAPE FLAVOR) AMOXICILLIN TRIHYDRATE 150 MG EQ.TO AMOXICILLIN 125 MG/ 5 ML POWDER FOR ORAL SUSPENSION BOTTLE FOR THE TREATMENT OF SUSCEPTIBLE INFECTIONS INCLUDING URINARY-TRACT INFECTION, SINUSITIS, OTITIS MEDIA, UNCOMPLICATED COMMUNITY-ACQUIRED PNEUMONIA, ORAL INFECTION, LYME DISEASE, SALMONELLOSIS AND CYSTIC FIBROSIS NULL LAO INTER PHARMA CO.,LTD T MAN PHARMA COMPANY LIMITED THAILAND CERTIFICATE RELEASED 01 I 5172/22 21-MAY-2025 20-MAY-2030 View
1513 MANMOX -250 DRY SYRUP AMOXICILLIN TRIHYDRATE 286.98 MG EQ.TO AMOXICILLIN 250 MG / 5 ML POWDER FOR ORAL SUSPENSION BOTTLE FOR THE TREATMENT OF SUSCEPTIBLE INFECTIONS INCLUDING URINARY-TRACT INFECTION, SINUSITIS, OTITIS MEDIA, UNCOMPLICATED COMMNUTY-ACQUIRED PNEUMONIA, ORAL INFECTION, LYME DISEASE, SALMONELLOSIS AND CYSTIC FIBROSIS NULL LAO INTER PHARMA CO.,LTD T MAN PHARMA COMPANY LIMITED THAILAND CERTIFICATE RELEASED 01 I 5173/22 21-MAY-2025 20-MAY-2030 View
1514 METFORMIN RX METFORMIN HCL 500 MG FILM-COATED TABLETS ALU-STRIP MANAGEMENT OF TYPE 2 DIABETS MELLITUS AS MONO THERAPY WHEN HYPERGLYCEMIA CAN NOT BE MANAGED WITH DIET AND EXCERCISE ALONE, IN ADULT MAY BE USED CONCOMITANTLY WITH A SULFONYLUREA OR INSULIN TO IMPROVE GLYCEMIC CONTROL NULL LAO INTER PHARMA CO.,LTD R X MANUFACTURING CO., LTD THAILAND CERTIFICATE RELEASED 05 I 4035/15 07-FEB-2025 06-FEB-2030 View
1515 METFORMIN RX 850 METFORMIN HYDROCHLORIDE 850 MG FILM COATED TABLET ALU-STRIP MANAGEMENT OF TYPE 2 DIABETS MELLITUS AS MONO THERAPY WHEN HYPERGLYCEMIA CAN NOT BE MANAGED WITH DIET AND EXCERCISE ALONE, IN ADULT MAY BE USED CONCOMITANTLY WITH A SULFONYLUREA OR INSULIN TO IMPROVE GLYCEMIC CONTROL NULL LAO INTER PHARMA CO.,LTD R X MANUFACTURING CO.,LTD THAILAND CERTIFICATE RELEASED 05 I 5107/21 07-FEB-2025 06-FEB-2030 View
1516 MONTIGET PAEDIATRIC MONTELUKAST SODIUM EQ.TO MONTELUKAST 4 MG GRANULES FOR SUSPENSION SACHET IS INDICATED IN ADULT AND PEDIATRIC PATIENTS 6 MONTHS OF AGE AND OLDER FOR THE PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA INCLUDING: THE PREVENTION OF DAY AND NIGHT TIME SYMPTOMS, TREATMENT OF ASPIRIN-SENSITIVE ASTHMATIC PATIENTS… NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 3105/08 10-Feb-2023 09-Feb-2026 View
1517 MONTIGET TABLET 10 MG MONTELUKAST SODIUM EQ.TO MONTELUKAST 10 MG FILM-COATED TABLETS BLISTERPACK INDICATED FOR THE TREATMENT OF ADULTS WITH MILD, MODERATE AND SEVERE INFECTIONS CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROORGANISMS IN THE CONDITIONS LISTED BELOW: ACUTE BACTERIAL SINUSITIS, ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS… NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 3106/08 10-Feb-2023 09-Feb-2026 View
1518 MONTIGET TABLET 4 MG MONTELUKAST SODIUM EQ.TO MONTELUKAST 4 MG CHEWABLE TABLET ALU-ALU IS INDICATED IN ADULT AND PEDIATRIC PATIENTS 6 MONTHS OF AGE AND OLDER FOR THE PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA INCLUDING: THE PREVENTION OF DAY AND NIGHT TIME SYMPTOMS, TREATMENT OF ASPIRIN-SENSITIVE ASTHMATIC PATIENTS… NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 3110/08 10-Feb-2023 09-Feb-2026 View
1519 MONTIGET TABLETS 5 MG MONTELUKAST SODIUM EQ.TO MONTELUKAST 5 MG CHEWABLE TABLET ALU-ALU IS INDICATED IN ADULT AND PEDIATRIC PATIENTS 6 MONTHS OF AGE AND OLDER FOR THE PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA INCLUDING: THE PREVENTION OF DAY AND NIGHT TIME SYMPTOMS, TREATMENT OF ASPIRIN-SENSITIVE ASTHMATIC PATIENTS… NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 3109/08 10-Feb-2023 09-Feb-2026 View
1520 MYPAROF TABLET PARACETAMOL 450 MG, ORPHENADRINE CITRATE 35 MG TABLET BAG FOR THE TREATMENT OF MILD TO MODERATE PAIN INCLUDING HEADACHE, MIGRAINE, NEURALGIA, TOOTHACHE, SORETHROAT, PEROID PAINS, ACHES AND PAINS, SYMPTOMATIC RELIEF OF RHEUMATIC ACHES AND PAIN AND OF INFLUENZA, FEVERISHNESS AND FEVERISH COLDS NULL LAO INTER PHARMA CO.,LTD T MAN PHARMA COMPANY LIMITED THAILAND CERTIFICATE RELEASED 07 I 5242/22 21-MAY-2025 20-MAY-2030 View